Advertisement

Topics

Outcome Health Company Profile

06:51 EDT 15th August 2018 | BioPortfolio

Outcome Health’s mission is to activate the best health outcome possible for every person in the world through technologies that change behavior to positively shape the human condition. Founded in 2006, Outcome Health serves health information and health intelligence during critical moments of care to enable patients and physicians to make the best healthcare decision possible. Across the country, Outcome Health has over 150,000 digital devices and a presence in over 40,000 physician offices and health systems in its BPA certified network.


News Articles [205 Associated News Articles listed on BioPortfolio]

Apricus Biosciences Announces Outcome of Vitaros™ End-of-Review Meeting with FDA

FDA Confirms Vitaros Regulatory Pathway  Company Seeking Partner to Develop Vitaros in U.S. Company Evaluating Strategic Alternatives SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Ap...

SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX®

NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a health security company specializing in the development and commercialization of solutions for serious u...

Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore

MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) announced today that the U.S. International Trade Commission (the “ITC”) has termin...

Outcome from DSMB Safety Review and Extension of TACTI-mel Phase I Clinical Trial

SYDNEY, Australia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) (“Immutep” or the “Company”), announced today that the Database Safety Monitoring Board (“DS...

Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore

MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered ...

INSYS Therapeutics Confirms Outcome of FDA Advisory Committee Meeting on Buprenorphine Sublingual Spray

PHOENIX, May 22, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology,...

ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation

Single Phase 3 trial may be sufficient for approval of atrial fibrillation indicationPhase 3 clinical trial Special Protocol Assessment submission anticipated 3Q2018Gencaro is in development as poten...

Tonix Pharmaceuticals Announces Outcome of Interim Analysis for Phase 3 HONOR Study of Tonmya® in Military-Related PTSD

HONOR Study will Stop due to Inadequate Separation from Placebo at Week-12 Results at Week-4 Demonstrated Meaningful Clinical Improvement Company Plans to Meet with FDA to Discuss Next Steps for ...

PubMed Articles [3583 Associated PubMed Articles listed on BioPortfolio]

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial.

After coronary artery bypass graft (CABG) surgery in individuals with type 2 diabetes, there remains a considerable residual cardiovascular risk. In the EMPA-REG OUTCOME® trial in participants with t...

Peer effects in health valuation: the relation between rating of contemporaries' health and own health.

Most health valuation studies assume that individuals' health valuations do not depend on social comparisons. However, there is some evidence that this assumption is not satisfied in practice. This pa...

Local Health Departments' Engagement in Addressing Health Disparities: The Effect of Health Informatics.

Health disparities and health inequities can lead to poor health outcomes. However, health disparities continue to persist in communities across the United States, presenting a crucial public health c...

What Obstetrician-Gynecologists Should Know About Population Health.

Although there is much discussion about population health in academic medical centers, managed care organizations, and a variety of disciplines, it is not always clear what this term means. Population...

An Assessment of Organizational Health Literacy Practices at an Academic Health Center.

Organizational health literacy is the degree to which an organization considers and promotes the health literacy of patients. Addressing health literacy at an organizational level has the potential to...

Clinical Trials [2915 Associated Clinical Trials listed on BioPortfolio]

Implementation of a Best Practice Primary Health Care Model for Low Back Pain

POPULATION: Low back pain (LBP) is a major health problem commonly requiring health care. In Sweden, primary care professionals require an evidenced based model of care for LBP. INTERVENT...

Comparing Program Options for Latinos With Diabetes

BACKGROUND AND SIGNIFICANCE: Diabetes is a national health problem, yet Latinos from low-income households are at greater risk. Although guidelines recommend that patients learn self-mana...

Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).

Purpose: The overall hypothesis of the study is that the benefits attained in the EMPA-OUTCOME were, at least in part, mediated by a glucose-independent mechanism. Thus, to demonstrate th...

Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease

ABSTRACT CONTEXT: Inappropriate antibiotic prescriptions for acute bronchitis is a major public health concern because of antibiotic resistance. Effective therapies for managing the symp...

EMPA Acute Heart Failure

In this study the investigators are aiming to treat patients with acute heart failure with or without diabetes with Empagliflozin or placebo. Given the beneficial effects of Empagliflozin ...

Companies [1780 Associated Companies listed on BioPortfolio]

Outcomes Pharmaceutical Health Care

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides serv...

Outcome

Outcome is the leading provider of strategies and solutions designed to meet the unique needs of the post-approval market. The Company focuses on program strategy and the practical deployment of regis...

Outcome Sciences, Inc.

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides serv...

NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB (www.neurovive.com) is a Swedish drug development company whose primary mission is to develop drugs for the treatment of acute brain injury, reperfusion injury in myocard...

Innovation Health

Innovation Health provides health benefit plans to more than 200,000 members. The product of a unique Aetna and Inova Health System partnership, Innovation Heal...

More Information about "Outcome Health" on BioPortfolio

We have published hundreds of Outcome Health news stories on BioPortfolio along with dozens of Outcome Health Clinical Trials and PubMed Articles about Outcome Health for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Outcome Health Companies in our database. You can also find out about relevant Outcome Health Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record